Lessons from single gene disorders

doi:10.1017/CBO9780511543555.011

10 - Lessons from single gene disorders

Published online by Cambridge University Press: 17 August 2009

Nicholas D. Hastie

Edited by

Alan Wright and

Nicholas Hastie

Show author details

Alan Wright: Affiliation:
MRC Human Genetics Unit, Edinburgh
Nicholas Hastie: Affiliation:
MRC Human Genetics Unit, Edinburgh

Book contents

Get access

Summary

Introduction

It has been estimated that there are on the order of 6000 single gene disorders, most inherited as X-linked recessive, autosomal dominant or autosomal recessive Mendelian conditions (McKusick, 1998). In total, approximately 1% of the population is born with or will develop a disease through carrying such single gene mutations.

Even before the completion of the Human Genome sequence (International Human Genome Sequencing Consortium, 2001; Venter et al., 2001), heroic positional cloning efforts had successfully identified the genes mutated in 1000 or so of these disorders. Since the genome sequence has been available, the remainder are being picked off at an astonishing rate, the limiting factor now being the small number of affected individuals in some of the most rare conditions.

Identification of the genes mutated in Mendelian disorders has led to profound insights into disease mechanisms and, in some instances, has already had a clinical impact. Perhaps the most dramatic examples are phenylketonuria and bowel cancer, where identification of the underlying genetic cause has led to cures through nutritional and surgical intervention, respectively. In a number of cases, identification of the genes has enabled prenatal diagnosis with the offer of termination of pregnancy. Finally, in a few conditions the genetic breakthroughs have led to novel therapies, either pharmacological or immunological. Another enormous bonus is the profound impact that knowledge of these genes and their products has had on our understanding of basic biological processes.

Type: Chapter
Information: Genes and Common Diseases
Genetics in Modern Medicine
, pp. 152 - 163

DOI: https://doi.org/10.1017/CBO9780511543555.011 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Bartek, J., Bartkova, J. and Lukas, J. (1996). The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol, 8, 805–14.CrossRef Google Scholar PubMed

Bejerano, G., Pheasant, M., Makunin, I.et al. (2004). Ultraconserved elements in the human genome. Science, 304, 1321–5.CrossRef Google Scholar PubMed

Bates, G., Harper, P. and Jones, L. (2002). Huntington's disease. 3rd edn. Oxford: Oxford University Press.Google Scholar

Dalkilic, I. and Kunkel, L. M. (2003). Muscular dystrophies: genes to pathogenesis. Curr Opin Genet Dev, 3, 231–8.CrossRef Google Scholar

Farrington, S. M. and Dunlop, M. G. (2004). Familial colon cancer syndromes and their genetics. In Eeles, R. A., Easton, D. F., Ponder, B. A. J. and Eng, C. eds., Genetic predisposition to cancer. London: Arnold Publishers, pp. 315–31.Google Scholar

Fodde, R., Smits, R. and Clevers, H. (2001). APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer, 1, 55–67.CrossRef Google Scholar PubMed

Goldstein, J., Hobbs, H. and Brown, M. (2001). Familial hypercholesterolemia. In Scriver, C., Beaudet, A., Sly, W. and Valle, D., eds., The Metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp. 2863–913.Google Scholar

Grosshans, H. and Slack, F. J. (2002). Micro-RNAs: small is plentiful. J Cell Biol, 156, 17–21.CrossRef Google Scholar

Grosveld, F., Assendelft, G., Greaves, D. and Kollias, G. (1987). Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell, 51, 975–85.CrossRef Google Scholar PubMed

International Human Genome Sequencing Consortium. (2001). Initial sequencing and analysis of the human genome. Nature, 409, 860–921.CrossRef

Janus, C., Pearson, J., McLaurin, J.et al. (2000). A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature, 408, 979–82.CrossRef Google Scholar

Kleinjan, D. A. and Heyningen, V. (2005). Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet, 76, 8–32.CrossRef Google Scholar

Krawczak, M., Ball, E. V., Fenton, I.et al. (2000). Human gene mutation database – a biomedical information and research resource. Hum Mutat, 15, 45–51.3.0.CO;2-T>CrossRef Google Scholar PubMed

Lettice, L. A., Heaney, S. J., Purdie, L. A.et al. (2002). Disruption of a long-range cis-acting regulator for SHH causes preaxial polydactyly. Proc Natl Acad Sci USA, 99, 7548–53.CrossRef Google Scholar PubMed

Lettice, L. A., Heaney, S. J., Purdie, L. A.et al. (2003). A long-range SHH enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet, 12, 1725–35.CrossRef Google Scholar PubMed

Liu, H.-X, Cartegni, L., Zhang, M. Q. and Krainer, A. R. (2001). A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet, 27, 55–8.CrossRef Google Scholar PubMed

Myers, R. H., Schaefer, E. J., Wilson, P. W.et al. (1996). Apolipoprotein E ε4 association with dementia in a population-based study: the Framingham Study. Neurology, 46, 673–7.CrossRef Google Scholar

McKusick, V. A. (1998). Mendelian inheritance in man. A catalog of human genes and genetic disorders, 12th edn. Baltimore, MD: Johns Hopkins University Press.Google Scholar

Pharoah, P. D., Antoniou, A., Bobrow, M.et al. (2002). Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet, 31, 33–6.CrossRef Google Scholar

Roses, A. D. (1996). Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med, 47, 387–400.CrossRef Google Scholar PubMed

Rozmahel, R., Wilschanski, M., Matin, A.et al. (1996). Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet, 12, 280–87.CrossRef Google Scholar PubMed

Sijbrands, E. J. G., Westendorp, R. G. J., Defesche, J. C.et al. (2001). Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ, 322, 1019–22.CrossRef Google Scholar PubMed

Tanzi, R. E. and Bertram, L. (2005). Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell, 120, 545–55.CrossRef Google Scholar PubMed

The Cystic Fibrosis Genotype–Phenotype Consortium (1993). Correlation between genotype and phenotype in patients with cystic fibrosis. New Engl J Med, 329, 1308–13.CrossRef

The US–Venezuela Collaborative Research Project and Wexler, N. S. (2004). Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci USA, 101, 3498–503.CrossRef

Venter, J. C., Adams, M. D., Myers, E. W.et al. (2001). The sequence of the human genome. Science, 291, 1304–35.CrossRef Google Scholar PubMed

Weatherall, D. J. (2001). Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias. Nat Rev Genet, 2, 245–55.CrossRef Google Scholar PubMed

Wright, A. F. and Hastie, N. D. (2001). Complex genetic diseases-controversy over the Croesus code. Genome Biol, 2, 2007.1–2007.8.Google Scholar PubMed

Zielenski, J. and Tsui, L.-C (1995). Cystic fibrosis: genetypic and phenotypic variations. Annu Rev Genet, 29, 777–807.CrossRef Google Scholar

Zielenski, J., Corey, M., Rozmahel, R.et al. (1999). Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet, 22, 128–9.CrossRef